<DOC>
	<DOCNO>NCT02136498</DOCNO>
	<brief_summary>The purpose pilot study evaluate acceptability feasibility propose smoke cessation intervention ( call MyMAP My Mobile Advice Program ) .</brief_summary>
	<brief_title>My Mobile Advice Program : A Randomized Pilot Feasibility Study</brief_title>
	<detailed_description>Investigators develop pilot test prototype MyMAP intervention.The intervention design help smoker well manage issue know reduce treatment adherence ( withdrawal symptom , medication side-effects , low motivation , inadequate behavioral skill medication adherence ) facilitate great communication patient provider clinician provide appropriate oversight medication use , intervene medically necessary , address patient concern may otherwise lead non-adherence early treatment termination .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>An invited member Group Health , health care system Pacific Northwest Plan remain enrolled Group Health next 6 month age 18 65 Eligible smoke cessation treatment Group Health insurance coverage smoke &gt; = 10 cigs day speak read English willing use varenicline contraindication medication ready quit smoke smart phone internet access willing receive study text email receive care Group Health clinic electronic medical record system fill prescription Group Health pharmacy agree use birth control take study medication , risk pregnancy lifetime history dementia psychosis bipolar disorder base selfreport medical record review hearing , comprehension visual limitation preclude full study participation current use form tobacco medical contraindication varenicline use document history suicidal ideation/intent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>varenicline</keyword>
	<keyword>adherence</keyword>
</DOC>